NCT01803945View on ClinicalTrials.gov

A Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AVE8112 in Patients With Parkinson's Disease

PHASE1TerminatedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Parkinson's Disease
Interventions
DRUG

AVE8112

DRUG

Placebo

Trial Locations (2)

Unknown

California Clinical Trials, Glendale

PARAXEL International, Baltimore

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Michael J. Fox Foundation for Parkinson's Research

OTHER